Biotechnology Companies in the News – February 2012

Editor’s Note: The home page of the BioNJ website provides an up-to-the-minute headline service where readers can access press releases issued by New Jersey-based biotechnology companies. Go to the “New Jersey Biotechnology Company News” section on the BioNJ home page to read the latest news. Companies wishing to appear in the Biolines Biotechnology Companies in… Read the full article


Industry News and Notes – February 2012

Trenton Report CCIT Awarded Soft-Landings International Incubator Designation TRENTON — New Jersey’s growing reputation as a prime location to place and grow a business was further validated recently when the National Business Incubation Association (NBIA) awarded its Soft Landings International Incubator designation to the Commercialization Center for Innovative Technologies (CCIT), which is part of the… Read the full article



Membership Update – February 2012

BioNJ welcomes Savient Pharmaceuticals as a new Diamond Member. Savient Pharmaceuticals, Inc. Savient Pharmaceuticals, Inc., is a specialty biopharmaceutical company focused on developing and commercializing KRYSTEXXA (pegloticase) for the treatment of chronic gout in adult patients refractory to conventional therapy. Savient has exclusively licensed worldwide rights to the technology related to KRYSTEXXA and its uses… Read the full article



BioNJ Headlines – February 2012

BioNJ Participates in Senate Democratic Committee Roundtable Discussion on Job Creation, Local Economy WASHINGTON, DC — U.S. Senator Robert Menendez (D-NJ) hosted two New Jersey business leaders at a discussion on February 1 with Senate Democrats about how they and other small and medium businesses are strengthening local economies and creating jobs, and about how… Read the full article